Literature DB >> 2802736

[Surgical treatment of vulvar cancer and plastic reconstruction of vulvar defects].

P G Knapstein1, M Mahlke, W Poleska, W Zeuner.   

Abstract

In recent years sufficient scientific and clinical data have become available to establish an individualized treatment plan for each patient suffering from vulvar carcinoma. Organ-preserving operations are strictly confined to "early cases" as described by a careful histopathology of the primary lesion. The high perioperative morbidity and the bad cosmetic results of extended radical vulvectomy are definitely improved by additional plastic reconstructive procedures. Neoadjuvant chemotherapy probably results in a better survival rate in lymph node positive patients.

Entities:  

Mesh:

Year:  1989        PMID: 2802736     DOI: 10.1007/bf02417399

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  Infiltrative carcinoma of the vulva: results of surgical treatment.

Authors:  G W Morley
Journal:  Am J Obstet Gynecol       Date:  1976-04-15       Impact factor: 8.661

2.  [Vulvar cancer].

Authors:  B U Sevin; H D Homesley
Journal:  Gynakologe       Date:  1986-06

3.  Individualization of treatment for stage I squamous cell vulvar carcinoma.

Authors:  N F Hacker; J S Berek; L D Lagasse; R K Nieberg; R S Leuchter
Journal:  Obstet Gynecol       Date:  1984-02       Impact factor: 7.661

4.  Carcinoma of the vulva: analysis of treatment and survival.

Authors:  K C Podratz; R E Symmonds; W F Taylor; T J Williams
Journal:  Obstet Gynecol       Date:  1983-01       Impact factor: 7.661

Review 5.  The case against the surgical concept of en bloc dissection for certain malignancies of the reproductive tract.

Authors:  P J DiSaia
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

6.  Microinvasive carcinoma of the vulva.

Authors:  E J Wilkinson; M J Rico; K K Pierson
Journal:  Int J Gynecol Pathol       Date:  1982       Impact factor: 2.762

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.